Antidiuretic
substance helps to control the fluid balance in the body. Their action is
opposite to that of diuretics which disrupt this balance. Major antidiuretic
drugs are vasopressin (also known as antidiuretic hormone (ADH)), desmopressin,
and oxytocin. In diabetes insipidus, antidiuretic drugs reduce the urine
volume. Desmopressin is widely used antidiuretic drug as it is relatively
inexpensive and safe having minimum adverse reactions to the body. It is
primarily used for treating patients with hemophilia.
Rising
prevalence of diabetes and other chronic disease such as cardiovascular
diseases, growing use of antidiuretic drugs for the treatment of hemophilia and
huge patient pool with hypertension, drives the growth of antidiuretic drugs
markets.
The global antidiuretic drugs market is expected to grow at a CAGR of 9.7% during the forecast period and is estimated to reach USD 180 million by 2023.
The global antidiuretic drugs market is expected to grow at a CAGR of 9.7% during the forecast period and is estimated to reach USD 180 million by 2023.
Key
Players in the Global Antidiuretic drugs Market
Some of the key players in this market are Par Sterile Products, LLC (U.S.), ADH Health (U.S.), Azevan Pharmaceuticals, Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Otsuka Holdings Co. Ltd (Japan), Taj Pharmaceuticals Limited (India) and ALLERGAN (U.S.).
Segments
The global antidiuretic drugs market is segmented on the basis of types, which includes vasopressin, desmopressin, oxytocin, and others. Other types of antidiuretic drugs are argipressin, lypressin, ornipressin and terlipressin. On the basis of indication, the market is segmented into diabetes insipidus, hemophilia, hypertension, and others. Diabetes insipidus is further sub-segmented into central diabetes insipidus, nephrogenic diabetes insipidus, dipsogenic diabetes insipidus and gestational diabetes insipidus. Other indications are polyuria, polydipsia and enuresis. On the basis of end users, the market is segmented into hospitals, clinics, pharmaceutical companies, and others.
Regional Analysis of the Global Antidiuretic drugs Market
The American region accounted for the largest share of the global market due to increasing prevalence of diabetes insipidus, and rising demand for new drugs for the treatment of diabetes insipidus. The rate of diabetes insipidus is much higher in America than the rest of the world. According to the Diabetes Insipidus Organization, in the U.S., 1 in 6,666 American may develop diabetes insipidus. According to International Diabetes Federation, in 2016, it was estimated that 420 million adult population was suffering from diabetes which is increasing at the rate of 8.4% and is expected to reach 625 million by 2040.
Some of the key players in this market are Par Sterile Products, LLC (U.S.), ADH Health (U.S.), Azevan Pharmaceuticals, Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Otsuka Holdings Co. Ltd (Japan), Taj Pharmaceuticals Limited (India) and ALLERGAN (U.S.).
Segments
The global antidiuretic drugs market is segmented on the basis of types, which includes vasopressin, desmopressin, oxytocin, and others. Other types of antidiuretic drugs are argipressin, lypressin, ornipressin and terlipressin. On the basis of indication, the market is segmented into diabetes insipidus, hemophilia, hypertension, and others. Diabetes insipidus is further sub-segmented into central diabetes insipidus, nephrogenic diabetes insipidus, dipsogenic diabetes insipidus and gestational diabetes insipidus. Other indications are polyuria, polydipsia and enuresis. On the basis of end users, the market is segmented into hospitals, clinics, pharmaceutical companies, and others.
Regional Analysis of the Global Antidiuretic drugs Market
The American region accounted for the largest share of the global market due to increasing prevalence of diabetes insipidus, and rising demand for new drugs for the treatment of diabetes insipidus. The rate of diabetes insipidus is much higher in America than the rest of the world. According to the Diabetes Insipidus Organization, in the U.S., 1 in 6,666 American may develop diabetes insipidus. According to International Diabetes Federation, in 2016, it was estimated that 420 million adult population was suffering from diabetes which is increasing at the rate of 8.4% and is expected to reach 625 million by 2040.
Europe is
the second largest market that holds a noticeable share of the global
antidiuretic drugs market. Diabetes insipidus is a common postoperative
complication among children who have undergone transsphenoidal craniotomy.
In Asia
Pacific, rising awareness about diabetes insipidus, huge geriatric population
suffering from diabetes insipidus and increase in the risk of developing
diabetes insipidus after surgery is driving the market growth. Furthermore,
rising awareness about the use of antidiuretic drugs for the treatment of
diabetes insipidus also propels the market growth.
Middle East and Africa show steady growth in the antidiuretic drugs market.
Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/4306
Middle East and Africa show steady growth in the antidiuretic drugs market.
Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/4306
TABLE OF CONTENT
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1
Definition
2.2
Scope Of The Study
2.2.1
Research Objective
2.2.2
Assumptions
2.2.3
Limitations
Chapter 3. Research Methodology
3.1
Introduction
3.2
Primary Research
3.3
Secondary Research
3.4
Market Size Estimation
Chapter 4. Market Dynamics
4.1
Drivers
4.2
Restrains
4.3
Opportunities
4.4
Challenges
4.5
Macroeconomic Indicators
4.6
Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1
Porters Five Forces Analysis
5.1.1
Bargaining Power Of Suppliers
5.1.2
Bargaining Power Of Buyers
5.1.3
Threat Of New Entrants
5.1.4
Threat Of Substitutes
5.1.5
Intensity Of Rivalry
About
US:
Market
Research Future (MRFR), enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports
(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market
Research & Consulting Services.
Contact
Us:
Market
Research Future
Office
No. 528, Amanora Chambers
Magarpatta
Road, Hadapsar,
Pune
- 411028
Maharashtra,
India
Phone:
+1 646 845 9312
Email:
sales@marketresearchfuture.com
No comments:
Post a Comment